4//SEC Filing
BioAmber Inc. 4
Accession 0001209191-16-093925
CIK 0001534287operating
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 1:34 PM ET
Size
5.6 KB
Accession
0001209191-16-093925
Insider Transaction Report
Form 4
BioAmber Inc.BIOA
Huc Jean-Francois
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2016-01-26+200,000→ 200,000 totalExercise: $5.00Exp: 2026-01-26→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The exercise price represents a premium of $0.86 per share over grant date closing market price of BioAmber Inc. common stock on the New York Stock Exchange of $4.14 per share.
- [F2]These options will vest as follows: 25% will vest on 01/26/2017; the remaining 75% will vest on a monthly basis over the three (3) following years.
Documents
Issuer
BioAmber Inc.
CIK 0001534287
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001534287
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 1:34 PM ET
- Size
- 5.6 KB